Respiri Share Price and Company Fundamentals
Last traded: Today at 6:10 AM
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes, medical devices in Australia and Israel. The company produces and sells mobile health applications. Its products include Wheezo, a mobile app, which has asthma management diary, medication usage and reminders, and symptoms and triggers to help asthma sufferers; and Wholter, a device for home ambulatory recording of nocturnal wheeze and cough. The company also offers PulmoTrack, a computerized wheeze detection product designed for hospital/clinical based real-time monitoring of wheeze and cough in the management of acute asthma in the ER and ICU, and for pediatric pulmonary function testing and sleep labs. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited is based in Melbourne, Australia.
|Primary activities||e-Health SaaS company supporting respiratory health management.|
|Industry / Sector||Medical Devices / Healthcare|
|Mailing address||432 St Kilda Road Suite 1 Level 9 Melbourne VIC 3004 Australia|
|Phone / Fax||61 3 9653 9160 /|
|Share registry||COMPUTERSHARE INVESTOR SERVICES PTY LIMITED|
Respiri does not pay dividends.
As of May 2021, following are the company executives and directors listed on Respiri.
|Mr. Nicholas Smedley||Exec. Chairman||88.98k|
|Mr. Marjan Mikel B.Sc., M.A.I.C.D.||CEO, MD & Exec. Director||420.15k|
|Dr. Samaneh Sarraf Shirazi||Chief Research Officer||180.08k|
|Mr. Philippe Ludekens||Gen. Mang. of Commercial Operations||228.97k|
|Mr. Peter Hildebrandt||Operations Mang.|
|Ms. Jan P. Barker||Vice-Pres of Bus. Devel.|
|Mr. Alastair Beard||Company Sec.|
|Prof. Noam Gavriely||Medical & Scientific Advisor|
|Mr. Simon Godfrey||Medical & Scientific Advisor|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Respiri is 71.56M and its enterprise value is 58.76M. The enterprise value to revenue ratio of RSH is 50.59.
Companies similar to Respiri (RSH)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Respiri (ASX:RSH) Frequently Asked Questions
1. What is Respiri's Stock Symbol?
Respiri trades on ASX under the ticker symbol "RSH".
2. What is Respiri's stock price today?
One share of RSH stock can currently be purchased for approximately $0.099.
3. How can I contact Respiri?
Respiri's mailing address is 432 St Kilda Road Suite 1 Level 9 Melbourne VIC 3004 Australia. The company can be reached via phone at 61 3 9653 9160.
4. What is Respiri's official website?
The official website of Respiri is http://www.respiri.co.
5. Which share registry manages Respiri's stock?
Respiri's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.